Cargando…

Mechanism of Notch1-saRNA-1480 reversing androgen sensitivity in human metastatic castration-resistant prostate cancer

The aim of the present study was to explore the mechanism by which Notch1-small activating (sa)RNA restored androgen sensitivity in human metastatic castration-resistant prostate cancer (CRPC). After transfection of Notch1-saRNA-1480 in PC3 cells, the expression of Notch1 and androgen receptor (AR)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Libin, Jiang, Kang, Jiang, Peiwu, He, Han, Chen, Kean, Shao, Jia, Deng, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255480/ https://www.ncbi.nlm.nih.gov/pubmed/32626918 http://dx.doi.org/10.3892/ijmm.2020.4597

Ejemplares similares

Gene activation of CEBPA using saRNA: Preclinical studies of the first in human saRNA drug candidate for liver cancer
por: Reebye, Vikash, et al.
Publicado: (2018)

The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta
por: Keikha, Reza, et al.
Publicado: (2021)

Therapeutic Potential of small Activating RNAs (saRNAs) in Human Cancers
por: Yoon, Sorah, et al.
Publicado: (2018)

Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
por: Liu, Yalan, et al.
Publicado: (2023)

Poly(2-oxazoline)/saRNA Polyplexes for Targeted and Nonviral Gene Delivery
por: Hayes, Graham, et al.
Publicado: (2023)

Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer
por: Marshall, Catherine H., et al.
Publicado: (2021)

saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription
por: Portnoy, Victoria, et al.
Publicado: (2016)

AB224. SaRNA guided inos upregulation improves erectile function of diabetic rats
por: Wang, T, et al.
Publicado: (2014)

Reactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells
por: ZHAO, FENG, et al.
Publicado: (2015)

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA
por: Blakney, Anna K., et al.
Publicado: (2019)

Histone lysine methyltransferase-related neurodevelopmental disorders: current knowledge and saRNA future therapies
por: Roth, Charlotte, et al.
Publicado: (2023)

Notch1 suppresses prostate cancer cell invasion via the metastasis-associated 1-KiSS-1 metastasis-suppressor pathway
por: Deng, Gang, et al.
Publicado: (2017)

Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis
por: Wang, Chenghe, et al.
Publicado: (2016)

Optimization of Lipid Nanoparticles for saRNA Expression and Cellular Activation Using a Design-of-Experiment Approach
por: Ly, Han Han, et al.
Publicado: (2022)

p21(CIP/WAF1) saRNA inhibits proliferative vitreoretinopathy in a rabbit model
por: Zhang, Qi, et al.
Publicado: (2023)

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer
por: Blakney, Anna K., et al.
Publicado: (2020)

Biophysical characterization of the structure of a SARS-CoV-2 self-amplifying RNA (saRNA) vaccine
por: Myatt, Daniel P, et al.
Publicado: (2023)

Enzalutamide: targeting the androgen signalling pathway in metastatic castration‐resistant prostate cancer
por: Schalken, Jack, et al.
Publicado: (2015)

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
por: Massaro, Maria, et al.
Publicado: (2021)

A Mutation in Endogenous saRNA miR-23a Influences Granulosa Cells Response to Oxidative Stress
por: Wang, Siqi, et al.
Publicado: (2022)

FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer
por: Ma, Libin, et al.
Publicado: (2020)

Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
por: Lavaud, Pernelle, et al.
Publicado: (2020)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Can local treatment prolong the sensitivity of metastatic prostate cancer to androgen deprivation or even prevent castration resistance?
por: Niklas, Christina, et al.
Publicado: (2021)

A Phase 1b Adaptive Androgen Deprivation Therapy Trial in Metastatic Castration Sensitive Prostate Cancer
por: Zhang, Jingsong, et al.
Publicado: (2022)

THU544 Prostatic Acid Phosphatase Is Negatively Regulated By Androgens And Persists In Castrate-resistant Metastatic Prostate Cancer
por: Rajagopalan, Vinodh, et al.
Publicado: (2023)

Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo
por: Yoon, Sorah, et al.
Publicado: (2016)

Roles of autophagy in androgen-induced benign prostatic hyperplasia in castrated rats
por: Liu, Rong-Fu, et al.
Publicado: (2018)

Dental Science in 1480—As Expounded by Peter De Largelata
por: Trueman, William H.
Publicado: (1900)

Dental Science in 1480, as Expounded by Peter De Largelata
por: Trueman, William H.
Publicado: (1899)

Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC
por: Yoon, Sorah, et al.
Publicado: (2019)

OX40 agonist stimulation increases and sustains humoral and cell-mediated responses to SARS-CoV-2 protein and saRNA vaccines
por: Duhen, Rebekka, et al.
Publicado: (2022)

saRNA vaccine expressing membrane-anchored RBD elicits broad and durable immunity against SARS-CoV-2 variants of concern
por: Komori, Mai, et al.
Publicado: (2023)

Survival Outcomes of Concurrent Treatment with Docetaxel and Androgen Deprivation Therapy in Metastatic Castration-Resistant Prostate Cancer
por: Jang, Ho Seong, et al.
Publicado: (2016)

Androgen Decline and Survival During Docetaxel Therapy in metastatic Castration Resistant Prostate Cancer (mCRPC)
por: Ryan, Charles J, et al.
Publicado: (2019)

Clinical characteristics of patients with metastatic castration-resistant prostate cancer after treatment with combined androgen blockade
por: Obinata, Daisuke, et al.
Publicado: (2023)

Sarna: una epidemia dentro de una pandemia
por: Casals, Miquel
Publicado: (2021)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
por: Stein, Mark N, et al.
Publicado: (2014)

Persistent androgen receptor addiction in castration-resistant prostate cancer
por: Schweizer, Michael T., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mma1j011e7j2cp2vsfeggt55ci